Insiders Are Buying These 11 Penny Stocks
In this article, we will take a detailed look at Insiders Are Buying These 11 Penny Stocks. For a quick overview of such stocks, read our article Insiders Are Buying These 5 Penny Stocks. US stock ma...
- Supported exchanges /
- NASDAQ /
- ALZN.NASDAQ
Alzamend Neuro Inc (ALZN NASDAQ) stock market data APIs
$1.65
0.01(0.6%)
as of October 17, 2024
Price chart is built with Anychart
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Alzamend Neuro Inc Financial Data Overview
| 1.64 | |
| 1.65 | |
| - | |
| 1.68 | |
| 1.51 | |
| 1.4-31.5 | |
| 7 429 K | |
| 4 475 K | |
| 0 | |
| -1.25 | |
| -0.026 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'ALZN',
Type:
'Common Stock',
Name:
'Alzamend Neuro Inc',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG00ZMXG7M8',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1677077',
EmployerIdNumber:
NULL,
FiscalYearEnd:
'April',
IPODate:
'2021-06-15',
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
HomeCategory:
NULL,
IsDelisted:
false,
}
Alzamend Neuro Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -7 323 379
- Earnings Per Share -142.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Alzamend Neuro Inc Earnings via APIs
- Latest Release 2024-09-11
- EPS/Forecast -2.38
Get Alzamend Neuro Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Alzamend Neuro Inc latest news via APIs
3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024
Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of biotech...
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
